Royalty Pharma: former affiliate plans $11.9M sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Royalty Pharma plc (RPRX) is named as issuer in a notice of a proposed sale of 206,352 Class A ordinary shares for the account of Errol B. De Souza, identified as a former affiliate. Errol Bento De Souza Revocable Trust will sell the shares, which have an aggregate market value of $11,925,082. The notice lists 445,277,344 Class A ordinary shares outstanding.
Key Figures
Key Terms
LP Interests financial
Aggregate Market Value financial
Revocable Trust regulatory
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is the RPRX sale expected, and which broker is named?
AI-generated analysis. How Rhea-AI works. Not financial advice.